Zhang L - Search Results

1

[Correlation between the kinetics of plasma EBV DNA levels and clinical response during treatment in patients with nasopharyngeal carcinoma].

Peng PJ, Zhao C, Liao H, Wang FQ, Zhang L. Peng PJ, et al. Among authors: zhang l. Ai Zheng. 2002 Aug;21(8):817-22. Ai Zheng. 2002. PMID: 12478884 Chinese.

2

Phase III study comparing standard radiotherapy with or without weekly oxaliplatin in treatment of locoregionally advanced nasopharyngeal carcinoma: preliminary results.

Zhang L, Zhao C, Peng PJ, Lu LX, Huang PY, Han F, Wu SX. Zhang L, et al. J Clin Oncol. 2005 Nov 20;23(33):8461-8. doi: 10.1200/JCO.2004.00.3863. Epub 2005 Oct 17. J Clin Oncol. 2005. PMID: 16230677 Clinical Trial.

3

[Prognostic impact of plasma Epstein-Barr virus DNA concentration on distant metastasis in nasopharyngeal carcinoma].

Hou X, Zhang L, Zhao C, Li S, Lu LX, Han F, Shao JY, Huang PY. Hou X, et al. Among authors: zhang l. Ai Zheng. 2006 Jul;25(7):785-92. Ai Zheng. 2006. PMID: 16831265 Chinese.

4

Phase II clinical study of gemcitabine in the treatment of patients with advanced nasopharyngeal carcinoma after the failure of platinum-based chemotherapy.

Zhang L, Zhang Y, Huang PY, Xu F, Peng PJ, Guan ZZ. Zhang L, et al. Among authors: zhang y. Cancer Chemother Pharmacol. 2008 Jan;61(1):33-8. doi: 10.1007/s00280-007-0441-8. Epub 2007 Mar 20. Cancer Chemother Pharmacol. 2008. PMID: 17909810 Clinical Trial.

5

Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.

Shao JY, Li YH, Gao HY, Wu QL, Cui NJ, Zhang L, Cheng G, Hu LF, Ernberg I, Zeng YX. Shao JY, et al. Among authors: zhang l. Cancer. 2004 Mar 15;100(6):1162-70. doi: 10.1002/cncr.20099. Cancer. 2004. PMID: 15022282 Free article.

6

[Effect of epidermal growth factor receptor-selective tyrosine kinase inhibitor gefitinib on nasopharyngeal carcinoma xenografts].

Wang SS, Guan ZZ, Xiang YQ, Jiang WQ, Lin TY, Zhang L. Wang SS, et al. Among authors: zhang l. Ai Zheng. 2004 Nov;23(11 Suppl):1365-9. Ai Zheng. 2004. PMID: 15566638 Chinese.

7

[Effect of epidermal growth factor receptor-selective tyrosine kinase inhibitor ZD1839 on nasopharyngeal carcinoma cells].

Wang SS, Guan ZZ, Jiang WQ, Lin TY, Zhang L. Wang SS, et al. Among authors: zhang l. Ai Zheng. 2004 May;23(5):540-4. Ai Zheng. 2004. PMID: 15142450 Chinese.

8

[Relationship of serum level of dihydropyrimidine dehydrogenase and serum concentration of 5-fluorouracil to treatment response and adverse events in colorectal cancer patients].

Dong QM, He YJ, Li S, Zhou ZM, Zhang L, Zhou ZW, Xia ZJ, Li YY. Dong QM, et al. Among authors: zhang l. Ai Zheng. 2005 Apr;24(4):483-7. Ai Zheng. 2005. PMID: 15820075 Chinese.

9

[Efficacy of gefitinib on Chinese patients with locally advanced or metastatic non-small cell lung cancer: a clinical trial].

Guan ZZ, Zhang L, Li LY, Jiang GL, Liu XY, Chu DT, Zhao HY, Li W. Guan ZZ, et al. Among authors: zhang l. Ai Zheng. 2005 Aug;24(8):980-4. Ai Zheng. 2005. PMID: 16086877 Clinical Trial. Chinese.

10

[Effect of expression of coxsackie and adenovirus receptor on antitumor activity of genetically modified adenovirus].

Yuan ZY, Guan ZZ, Zhang L, Xu RH. Yuan ZY, et al. Among authors: zhang l. Ai Zheng. 2005 Apr;24(4):502-5. Ai Zheng. 2005. PMID: 15820079 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

132,619 results

Search Page

Filters